Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Derosa

Showing results (61-70 of 250) with videos related to

Pageof 25
Sort By:
Frontiers in Immunology|July 15, 2021
Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related ComplicationsGiuseppe Derosa, Pamela Maffioli, Angela D'Angelo, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 2, 2019
Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patientsGiuseppe Derosa, Maria Divina Pascuzzo, Angela D'Angelo, et al.
Vascular Health and Risk Management|March 18, 2010
Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipineRoberto Fogari, Amedeo Mugellini, Paola Preti, et al.
Journal of Medicinal Food|August 15, 2015
Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter StudyArrigo F G Cicero, Giuseppe Derosa, Livia Pisciotta, et al.
Drug Design, Development and Therapy|September 11, 2018
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patientsGiuseppe Derosa, Giovanni Gaudio, Gianfranco Pasini, et al.
European Journal of Gastroenterology & Hepatology|March 26, 2013
Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metforminPamela Maffioli, Elena Fogari, Angela D'Angelo, et al.
Clinical Therapeutics|May 17, 2003
Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factorsGiuseppe Derosa, Amedeo Mugellini, Leonardina Ciccarelli, et al.
Phytotherapy Research : PTR|February 5, 2019
Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patientsGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.
Cytokine|December 8, 2019
Adipose tissue dysfunction and metabolic disorders: Is it possible to predict who will develop type 2 diabetes mellitus? Role of markErs in the progreSsion of dIabeteS in obese paTIeNts (The RESISTIN trial)Giuseppe Derosa, Gabriele Catena, Giovanni Gaudio, et al.
Autoimmunity Reviews|January 10, 2016
Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trialsAmirhossein Sahebkar, Jana Rathouska, Giuseppe Derosa, et al.
Pageof 25

Showing results (61-70 of 250) with videos related to

Sort By:
Pageof 25
Frontiers in Immunology|July 15, 2021
Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related ComplicationsGiuseppe Derosa, Pamela Maffioli, Angela D'Angelo, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 2, 2019
Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patientsGiuseppe Derosa, Maria Divina Pascuzzo, Angela D'Angelo, et al.
Vascular Health and Risk Management|March 18, 2010
Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipineRoberto Fogari, Amedeo Mugellini, Paola Preti, et al.
Journal of Medicinal Food|August 15, 2015
Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter StudyArrigo F G Cicero, Giuseppe Derosa, Livia Pisciotta, et al.
Drug Design, Development and Therapy|September 11, 2018
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patientsGiuseppe Derosa, Giovanni Gaudio, Gianfranco Pasini, et al.
European Journal of Gastroenterology & Hepatology|March 26, 2013
Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metforminPamela Maffioli, Elena Fogari, Angela D'Angelo, et al.
Clinical Therapeutics|May 17, 2003
Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factorsGiuseppe Derosa, Amedeo Mugellini, Leonardina Ciccarelli, et al.
Phytotherapy Research : PTR|February 5, 2019
Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patientsGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.
Cytokine|December 8, 2019
Adipose tissue dysfunction and metabolic disorders: Is it possible to predict who will develop type 2 diabetes mellitus? Role of markErs in the progreSsion of dIabeteS in obese paTIeNts (The RESISTIN trial)Giuseppe Derosa, Gabriele Catena, Giovanni Gaudio, et al.
Autoimmunity Reviews|January 10, 2016
Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trialsAmirhossein Sahebkar, Jana Rathouska, Giuseppe Derosa, et al.
Pageof 25